Outcomes of Treatment With Guselkumab in Patients With Pityriasis Rubra Pilaris
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Guselkumab for Pityriasis Rubra Pilaris and Dysregulation of IL-23/IL-17 and NFkB Signaling: A Nonrandomized Trial
JAMA Dermatol 2024 Apr 10;[EPub Ahead of Print], RC Velasco, C Shao, B Cutler, J Strunck, G Kent, PB Cassidy, K Choate, TM GreilingFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.